Track lung disease changes in systemic sclerosis
Part of Lungs & breathing, Skin clinical trials.
This study follows people with systemic sclerosis who also have lung scarring (interstitial lung disease). It aims to map how lung function and lung images change over time, which may help doctors predict and better manage disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have systemic sclerosis diagnosed using 2013 ACR/EULAR criteria
- You have lung scarring (interstitial lung disease) seen on a chest HRCT scan
- You have breathing test results (PFTs) from when your lung disease was first diagnosed
- You have at least one additional breathing test during follow-up
- Your lung scarring is not from another cause (like silicosis, sarcoidosis, or lung cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patterns seen on a high-resolution CT (HRCT) scan to better understand lung disease that can occur with systemic sclerosis. It may help doctors recognize which lung changes go with which type of disease.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study looks at what factors contribute to worsening lung scarring seen on scans in people with certain lung diseases. Results may help doctors better understand and predict who will worsen over time.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This study looks at using chest CT scans to help predict how lung disease from scleroderma (SSc-ILD) may progress. It may help doctors better understand your condition.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.